Fred Lyagoba

1.5k total citations
22 papers, 596 citations indexed

About

Fred Lyagoba is a scholar working on Infectious Diseases, Virology and Hepatology. According to data from OpenAlex, Fred Lyagoba has authored 22 papers receiving a total of 596 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Infectious Diseases, 18 papers in Virology and 4 papers in Hepatology. Recurrent topics in Fred Lyagoba's work include HIV Research and Treatment (18 papers), HIV/AIDS Research and Interventions (14 papers) and HIV/AIDS drug development and treatment (13 papers). Fred Lyagoba is often cited by papers focused on HIV Research and Treatment (18 papers), HIV/AIDS Research and Interventions (14 papers) and HIV/AIDS drug development and treatment (13 papers). Fred Lyagoba collaborates with scholars based in Uganda, United Kingdom and United States. Fred Lyagoba's co-authors include Pontiano Kaleebu, David Yirrell, Alleluiah Rutebemberwa, Dilys Morgan, Charles F. Gilks, Neil French, Jonathan Weber, Christine Watera, Jimmy Whitworth and Jessica Nakiyingi and has published in prestigious journals such as PLoS ONE, The Journal of Infectious Diseases and AIDS.

In The Last Decade

Fred Lyagoba

22 papers receiving 583 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fred Lyagoba Uganda 12 506 477 117 52 50 22 596
Karidia Diallo United States 18 509 1.0× 628 1.3× 168 1.4× 30 0.6× 65 1.3× 44 745
Caroline E. Mullis United States 14 362 0.7× 402 0.8× 222 1.9× 36 0.7× 46 0.9× 26 564
Beth Chaplin United States 9 451 0.9× 499 1.0× 144 1.2× 39 0.8× 27 0.5× 11 581
Louise B. Jørgensen Denmark 16 432 0.9× 472 1.0× 188 1.6× 58 1.1× 61 1.2× 30 604
José Carlos Couto-Fernandez Brazil 15 613 1.2× 610 1.3× 109 0.9× 61 1.2× 54 1.1× 41 714
J K Maniar India 11 319 0.6× 372 0.8× 146 1.2× 25 0.5× 46 0.9× 23 496
Kimdar Sherefa Kemal United States 9 297 0.6× 292 0.6× 81 0.7× 39 0.8× 53 1.1× 17 376
Kirsi Liitsola Finland 14 490 1.0× 490 1.0× 283 2.4× 50 1.0× 55 1.1× 39 702
Immaculate Nankya Uganda 17 944 1.9× 979 2.1× 193 1.6× 68 1.3× 122 2.4× 39 1.1k
Claire Mulanga-Kabeya France 9 548 1.1× 529 1.1× 224 1.9× 25 0.5× 71 1.4× 11 727

Countries citing papers authored by Fred Lyagoba

Since Specialization
Citations

This map shows the geographic impact of Fred Lyagoba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fred Lyagoba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fred Lyagoba more than expected).

Fields of papers citing papers by Fred Lyagoba

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fred Lyagoba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fred Lyagoba. The network helps show where Fred Lyagoba may publish in the future.

Co-authorship network of co-authors of Fred Lyagoba

This figure shows the co-authorship network connecting the top 25 collaborators of Fred Lyagoba. A scholar is included among the top collaborators of Fred Lyagoba based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fred Lyagoba. Fred Lyagoba is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kiwuwa-Muyingo, Sylvia, Deogratius Ssemwanga, Pauliina Ilmonen, et al.. (2017). HIV-1 transmission networks in high risk fishing communities on the shores of Lake Victoria in Uganda: A phylogenetic and epidemiological approach. PLoS ONE. 12(10). e0185818–e0185818. 28 indexed citations
2.
Reynolds, Steven J., Victor Ssempijja, Ronald M. Galiwango, et al.. (2016). Low Rates of Transmitted Drug Resistance Among Newly Identified HIV-1 Seroconverters in Rural Rakai, Uganda. AIDS Research and Human Retroviruses. 33(5). 448–451. 4 indexed citations
3.
Namakoola, Ivan, Billy N. Mayanja, Joseph Lutaakome, et al.. (2016). From antiretroviral therapy access to provision of third line regimens: evidence of HIV Drug resistance mutations to first and second line regimens among Ugandan adults. BMC Research Notes. 9(1). 515–515. 11 indexed citations
4.
Goodall, Ruth, Adele McCormick, Anne Kapaata, et al.. (2015). Gag-Protease Sequence Evolution Following Protease Inhibitor Monotherapy Treatment Failure in HIV-1 Viruses Circulating in East Africa. AIDS Research and Human Retroviruses. 31(10). 1032–1037. 11 indexed citations
5.
Birungi, Josephine, Jeong Eun Min, Katherine A. Muldoon, et al.. (2015). Lack of Effectiveness of Antiretroviral Therapy in Preventing HIV Infection in Serodiscordant Couples in Uganda: An Observational Study. PLoS ONE. 10(7). e0132182–e0132182. 15 indexed citations
6.
Parry, Chris M., Adele McCormick, Anne Kapaata, et al.. (2015). Evidence for Reduced Drug Susceptibility without Emergence of Major Protease Mutations following Protease Inhibitor Monotherapy Failure in the SARA Trial. PLoS ONE. 10(9). e0137834–e0137834. 21 indexed citations
7.
Kaleebu, Pontiano, Wilford Kirungi, Christine Watera, et al.. (2015). Virological Response and Antiretroviral Drug Resistance Emerging during Antiretroviral Therapy at Three Treatment Centers in Uganda. PLoS ONE. 10(12). e0145536–e0145536. 22 indexed citations
8.
Njai, Harr Freeya, Nicaise Ndembi, Josephine Birungi, et al.. (2012). Short Communication: HIV Type 1 Transmitted Drug Resistance and Evidence of Transmission Clusters Among Recently Infected Antiretroviral-Naive Individuals from Ugandan Fishing Communities of Lake Victoria. AIDS Research and Human Retroviruses. 29(5). 788–795. 26 indexed citations
9.
Ssemwanga, Deogratius, Nicaise Ndembi, Fred Lyagoba, et al.. (2011). HIV Type 1 Subtype Distribution, Multiple Infections, Sexual Networks, and Partnership Histories in Female Sex Workers in Kampala, Uganda. AIDS Research and Human Retroviruses. 28(4). 357–365. 26 indexed citations
10.
Serwanga, Jennifer, Fred Lyagoba, Susan Nakubulwa, et al.. (2011). Profile of T Cell Recognition of HIV Type 1 Consensus Group M Gag and Nef Peptides in a Clade A1- and D-Infected Ugandan Population. AIDS Research and Human Retroviruses. 28(4). 384–392. 10 indexed citations
11.
Lyagoba, Fred, David Dunn, Deenan Pillay, et al.. (2010). Evolution of Drug Resistance During 48 Weeks of Zidovudine/Lamivudine/Tenofovir in the Absence of Real-Time Viral Load Monitoring. JAIDS Journal of Acquired Immune Deficiency Syndromes. 55(2). 277–283. 21 indexed citations
12.
Ndembi, N., Ruth Goodall, David Dunn, et al.. (2009). Viral Rebound and Emergence of Drug Resistance in the Absence of Viral Load Testing: A Randomized Comparison between Zidovudine‐Lamivudine plus Nevirapine and Zidovudine‐Lamivudine plus Abacavir. The Journal of Infectious Diseases. 201(1). 106–113. 43 indexed citations
13.
McCormick, Adele, Andrew Burke, Fred Lyagoba, et al.. (2009). Prevalence and in vitro characteristics of reverse transcriptase (RT) N348I mutation in non-B subtypes, in the absence of viral load monitoring, in the DART Study (NORA substudy).. 2 indexed citations
14.
Ndembi, N., Ruth Goodall, Andrew Burke, et al.. (2008). Differences in the dynamics of viral rebound and evolution of resistance between CBV/NVP and CBV/ABC (NORA sub study of DART trial) uncovered in the absence of viral load monitoring in real time.. 1 indexed citations
15.
Munderi, Paula, A. Sarah Walker, C. Kityo, et al.. (2007). Discordance between virological/immunological and clinical outcomes at 48 weeks, in a randomised comparison of ZDV/3TC/NVP and ZDV/3TC/ABC in patients with low CD4 counts in Africa.. 1 indexed citations
16.
Pillay, Deenan, C. Kityo, Val J. Robertson, et al.. (2007). Emergence and evolution of drug resistance in the absence of viral load monitoring during 48 weeks of Combivir/Tenofovir within the DART Trial.. 8 indexed citations
17.
Kaleebu, Pontiano, Neil French, Cédric Mahé, et al.. (2002). Effect of Human Immunodeficiency Virus (HIV) Type 1 Envelope Subtypes A and D on Disease Progression in a Large Cohort of HIV‐1–Positive Persons in Uganda. The Journal of Infectious Diseases. 185(9). 1244–1250. 200 indexed citations
18.
Kaleebu, Pontiano, Amanda Ross, Dilys Morgan, et al.. (2001). Relationship between HIV-1 Env subtypes A and D and disease progression in a rural Ugandan cohort. AIDS. 15(3). 293–299. 91 indexed citations
19.
Kaleebu, Pontiano, David Yirrell, Neil French, et al.. (2000). An Improved Algorithm for Determining HIV Type 1 Subtypes in a Primary Laboratory in Uganda. AIDS Research and Human Retroviruses. 16(7). 621–625. 12 indexed citations
20.
Hamilton, Laura K., Alleluiah Rutebemberwa, Fred Lyagoba, et al.. (2000). Molecular Epidemiology of HIV Type 1 in a Rural Community in Southwest Uganda. AIDS Research and Human Retroviruses. 16(5). 393–401. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026